Dear Editor, Behavioural strategies are the cornerstone of managing paediatric insomnia, with pharmacological interventions rarely indicated. Despite this, use of both prescribed and over-the-counter melatonin has been on the rise. In response, The International Pediatric Sleep Association (IPSA) published expert consensus recommendations for healthcare providers for melatonin use in both typically developing children [1] and children with autism and other neurogenetic disorders [2].